Frankfurt
12.09.25 | 21:40
0,600 Euro
-10,45 % -0,070
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MEDICURE Aktie jetzt für 0€ handeln | |||||
| 21.08. | Medicure GAAP EPS of -$0.08, revenue of $6.7M | 1 | Seeking Alpha | ||
| 21.08. | Medicure steigert Umsatz und verringert Verlust im Q2 2025 | 1 | Investing.com Deutsch | ||
| 21.08. | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 20.08. | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended June 30, 2025 | 363 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / August 20, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 19.08. | Medicure Inc (2): Medicure to release Q2 results Aug. 20 | 1 | Stockwatch | ||
| 18.08. | Medicure, Inc.: Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 | 292 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / August 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and... ► Artikel lesen | |
| 18.06. | Medicure Inc (2): Medicure closes acquisition of West Olympia Pharmacy | 1 | Stockwatch | ||
| 18.06. | MEDICURE INC - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.06. | Medicure, Inc.: Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy | 833 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 21.05. | Medicure, Inc.: Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results | 513 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 21.05. | MEDICURE INC - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 28.04. | Medicure reports FY results | 8 | Seeking Alpha | ||
| 25.04. | MEDICURE INC - 20-F, Annual and transition report of foreign private issuers | 3 | SEC Filings | ||
| 23.04. | Medicure Inc (2): Medicure to release 2024 results April 29 | 5 | Stockwatch | ||
| 23.04. | Medicure, Inc.: Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024 | 365 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 11.04. | Medicure Inc (2): Medicure signs definitive deal to acquire West Olympia | 1 | Stockwatch | ||
| 11.04. | MEDICURE INC - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.04. | Medicure, Inc.: Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy | 330 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 12.03. | Medicure, Inc.: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy | 482 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / March 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen | |
| 18.02. | Medicure, Inc.: Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy | 282 | ACCESS Newswire | WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 46,730 | -0,14 % | Übernahmekandidat! Novo Nordisk und Eli Lilly bei BioNxt Solutions auf der Lauer | Eine Depotrakete für die kommenden Wochen? Da ist die Aktie von BioNxt Solutions mindestens einen Blick wert. Denn von Sommerloch konnte bei dem Unternehmen keine Rede sein. Stattdessen ging es Schlag... ► Artikel lesen | |
| PFIZER | 20,380 | +0,12 % | Investor Woche: EZB hält Zinsen stabil, Fed vor Dilemma, Klarna mit starkem IPO, Novo Nordisk streicht stellen, Pfizer, Prismo Metals, Sotheby's, Larry Ellison, Elon Musk | EZB belässt Zinsen stabil. Die Fed dürfte kommende Woche trotz hartnäckiger Inflation wegen dem schwachen Arbeitsmarkt die Zinsen senken. Klarna mit starkem IPO, Sotheby's leidet am Kunstmarkt. Novo... ► Artikel lesen | |
| GILEAD SCIENCES | 99,28 | +1,71 % | Veeva Systems: Gilead Sciences Commits to Veeva Vault CRM | Next generation CRM with deep capabilities and agentic AI
PLEASANTON, Calif., Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed... ► Artikel lesen | |
| AURORA CANNABIS | 4,170 | +0,36 % | Aurora Cannabis Inc (3): Aurora, Copeia launch English medical cannabis system | ||
| GSK | 17,450 | -0,91 % | Research and Markets: Europe Liver Disease Therapeutic Market Analysis Report 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffman-La Roche, Merck & Co., Novartis, Sanofi, Pfizer, Takeda - ResearchAndMarkets.com | The "Europe Liver Disease Therapeutic Market Forecast 2025" report has been added to ResearchAndMarkets.com's offering.
The Europe Liver Disease Therapeutic Market is expected to grow from US$... ► Artikel lesen | |
| ABBVIE | 187,00 | +0,43 % | AbbVie, Atai Life Sciences und Neural Therapeutics: Deals im Milliarden-Markt für Psychedelika | ||
| CANOPY GROWTH | 1,166 | +0,17 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| ELI LILLY | 640,30 | -0,76 % | Astra, Lilly are latest to reevaluate U.K. investments after Merck's pullback: reports | ||
| TILRAY BRANDS | 0,963 | +0,67 % | Tilray Brands, Inc. - 8-K, Current Report | ||
| BRISTOL-MYERS SQUIBB | 39,495 | +0,32 % | BioNTech SE: Erste Zwischenergebnisse aus BioNTechs und BMS' globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs | Daten zur Kombination des bispezifischen PD-L1xVEGF-A-Antikörper-Kandidaten Pumitamig (BNT327/BMS986545) mit Chemotherapie zeigen weiterhin ermutigende Anti-Tumor-Aktivitäten bei Patientinnen und Patienten... ► Artikel lesen | |
| TEVA | 17,050 | +0,29 % | Teva Pharmaceutical Industries Ltd: Teva's Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy | Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 336,30 | +0,06 % | Vertex Pharmaceuticals Incorporated: Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis | Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey Clinical Medical Research... ► Artikel lesen | |
| ABBOTT LABORATORIES | 113,68 | -0,26 % | Abbott reports first commercial Tendyne mitral valve implant in the U.S. | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| MPH HEALTH CARE | 17,900 | -2,98 % | EQS-DD: MPH Health Care AG: Brillant 4339. GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.08.2025 / 11:14... ► Artikel lesen |
MEDICURE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -10,45 % bei einem Aktienkurs von 0,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDICURE INC finden Sie auf Wallstreet Online.